The AMR Narrative

“Give me that antibiotic, my stomach is disturbing me”: The growing normalisation of metronidazole abuse

When Faridah walked into the pharmacy at our orientation camp, she needed a wonder drug: one that would immediately arrest her settling diarrhoea. She did not ask for a doctor, nor did she try to consult the pharmacists about what to take. “Give me that antibiotic”, she boldly demanded, pointing to the metronidazole container on the table, with her face marked with a frightening sense of urgency. “What for?” we asked. “My stomach is disturbing me; I have diarrhoea”. Our deepest concern was not that she requested the antibiotic outright, but the boldness and confidence with which she did. That confidence, no doubt, stemmed from how commonly metronidazole has been abused for diarrhoea. Even more troubling, this kind of request is becoming increasingly common among medical professionals and for a country like Nigeria, already grappling with antimicrobial resistance (AMR), this is an issue that must be tackled from the grassroots.

Metronidazole is an antibiotic not recommended for everyday use in treating diarrhoea because overuse can promote antimicrobial resistance. Frequent, unnecessary use also disrupts normal gut flora, reducing its effectiveness and increasing the risk of treatment failure when truly needed.

The AMR crisis in Nigeria is rapidly evolving. In 2019 alone, it was responsible for over 263,000 deaths (Biose, 2024). As a result, reports of antibiotic failure from laboratory tests across the country have become increasingly common. In many hospitals, AMR is now a familiar challenge. Within households, it is not uncommon to hear of cases where antibiotics have failed to work. For most people, when metronidazole fails to relieve symptoms, the next step is often to switch to a different class of antibiotics, perhaps Amoxicillin-Clavulanic acid or whatever they believe to be “stronger”. This behaviour only worsens the crisis of antibiotic misuse, especially in cases of diarrhoea that may be acute and self-limiting.

Metronidazole abuse has become so common that many people carry it in their bags, ready to take it at the slightest sign of stomach discomfort. In addition, people who suspect that the food they have eaten might upset their stomach often take a few doses of it. Due to its longstanding efficacy in managing a broad spectrum of intestinal conditions, many of which present with diarrhoea, metronidazole is often mistakenly perceived by the public as a medicine primarily intended for the treatment of diarrhoea. Uchendu et al., 2009 reported the widespread abuse of metronidazole among children, with half of the respondents admitting to giving antibiotics, primarily metronidazole (47.5%), to their children before seeking hospital care.

However, the abuse of metronidazole is not limited to Nigeria; it represents a global crisis. In Dodoma, Tanzania, Samson et al., 2023 found that 62% of female respondents reported using the drug as emergency contraceptive. In India, Chowdhury et al., 2012 reported the case of a man who developed dependency and continued abusing metronidazole, mebendazole, ornidazole, and albendazole for over 12 years, consuming up to 20 tablets daily. In addition, Yusuf et al., 2019 revealed that 57% laypeople took Metronidazole based on the number of stools they passed, rather than following standard dosing guidelines, raising serious concerns about both underdosing and overdosing.

Diarrhoea remains a significant public health challenge that can provoke fear and a heightened sense of urgency, especially among nursing mothers and adults who risk experiencing the distress of losing bowel control in public. This fear often acts as a driving force behind the misuse of antibiotics for diarrhoea, as people seek quick fixes without considering the underlying cause of the illness. According to the GBD 2021 Diarrhoeal Diseases Collaborators, diarrhoeal diseases accounted for an estimated 1.17 million deaths globally. Each year, the global cases of diarrhoea hits nearly 1.7 billion, with death tolls of about 443, 832 deaths among children under 5 and additional 50, 851 deaths among children aged 5 to 9 years (World Health Organisation, 2024).

Although statistics on the global burden of diarrhoea are frightening, it is worthy to note that diarrhoea is largely preventable; therefore, urgent efforts must be directed towards addressing the issue at its root through effective infection prevention and control and this can be achieved by promoting access to safe drinking water and nutrient-enriched foods.

In addition, improved sanitation, such as maintaining clean environments and implementing interventions to reduce or eliminate open defecation, can significantly reduce the incidence of diarrhoea. Hygiene practices, including hand washing with soap before preparing food, after eating, and after using the toilet, are equally essential. Food hygiene, such as proper cooking and storage of meals, and vaccination can also help slow the spread of diarrhoeal diseases.

Mass education is crucial to enhance public understanding of the symptoms, causes, and evidence-based treatment options for diarrhoea.

As health professionals, there is a growing need to lead campaigns that promote the responsible use of antibiotics in our communities and advocate for antimicrobial stewardship within healthcare facilities. These efforts are essential to correct public misconceptions about antibiotics and to strengthen trust in the healthcare system.

When Faridah received the Oral Rehydration Solution (ORS) and zinc tablets from us, she was initially sceptical; her mind was still fixated on the metronidazole she had requested. However, with proper counselling, she agreed to take the recommended treatment. By the next day, her diarrhoea had already begun to subside.

“If a safe alternative is equally effective, do not use antibiotics.” Let us preserve our antibiotics, so we do not run out of them when we need them the most. Above everything, always listen to the advice of a qualified medical professional.

Kenneth Chukwuebuka Egwu (B. Pharm, NIG)

Kenneth Egwu is a passionate global health pharmacist working to tackle the growing threat of antimicrobial resistance (AMR), especially in under-resourced communities across Africa. He co-founded the AMR Intervarsity Training Program. Kenneth also facilitates training at the Stop Superbugs Squad. In 2021, he was one of 25 students selected for the Ducit Blue Foundation One Health Pan-African AMR Internship/Mentorship Program. In 2022, he was also selected for the Future Leaders Against AMR program. His team reached the finals of the Innovate4Health competition with a project to reduce antibiotic misuse among farmers in Northern Nigeria.

In 2023, Kenneth received a grant from the PAR Foundation to educate and launch AMR Clubs across Nigerian universities. In 2024, he also won another grant from BSAC and is continuing to expand these clubs while raising AMR awareness through public engagement and online conversations. He has currently established AMR clubs in 35 tertiary institutions in Nigeria.

Disclaimer: The information provided on this website is intended for educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Reliance on any information provided on this website is solely at your own risk. The website owners and authors are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. It is recommended that you consult a qualified healthcare professional for individualised medical and health-related guidance.

Dr Marie-Anne Bouldouyre

Dr Marie-Anne Bouldouyre is an infectious diseases physician and hospital practitioner in Paris. Twelve years of clinical work in a suburban hospital shaped her understanding of access to care, patient relationships, and the daily reality of antimicrobial resistance.

Since 2022, she has led the Regional Antibiotic Stewardship Centre in Île-de-France and coordinates the national network, working with a multidisciplinary team to promote responsible antibiotic use and strengthen collaboration among healthcare professionals. She also continues to manage complex infections at Saint-Louis Hospital.

Convinced that antimicrobial resistance cannot be tackled by healthcare workers alone, she advocates for the active involvement of patients : understanding, questioning, and taking part in decisions about antibiotics. Their stories are essential to making this issue visible and concrete.

She is proud to collaborate with initiatives such as The AMR Narrative and hopes to foster similar projects in France to give patients a voice in this shared fight.

Dr Erva Cinar

Dr Erva Cinar is a London based paediatric resident doctor and clinical researcher with interest in infectious diseases.

She is currently completing a Master’s in Public Health at the London School of Hygiene & Tropical Medicine. Through the World Medical Association’s Junior Doctor’s Network (WMA-JDN) AMR Working Group, she engages in policy and advocacy on antimicrobial resistance and stewardship at global level.

Alongside her clinical and academic roles, she works with the Royal College of Paediatrics and Child Health (RCPCH) and the International Child Health Group (ICHG); leads on organising teaching resources and educational events to improve research skills for UK paediatric trainees and for global child health professionals.

Hamu Madzedze

Hamu Madzedze is a seasoned Zimbabwean journalist with over 15 years’ experience.

She previously worked for the Zimbabwe Broadcasting Corporation as a reporter and sub-editor, before establishing an independent website, 365HealthDiaries, which focuses on health and gender issues.

She holds a BA in Media Studies and a BA (Special Honours) in Communication and Media from the Zimbabwe Open University, as well as a diploma from the Christian College of Southern Africa.

Her work has been recognised with several awards, including the Global AMR Special Mention Award (2024), the Sexual Health Rights and Equity Fellowship Special Mention Award (2025), and the Merck Foundation Award (2024) for outstanding coverage of health issues, gender, infertility, and genital mutilation, where she achieved third position in the Online Category.

Hamu is passionate about addressing AMR through the media.

Jomana F. Musmar

Dr. Jomana Musmar is a distinguished global policy expert and proactive leader with over fifteen years of government experience in strategic planning, operational design, and policy execution. Renowned for simplifying complex topics with expertise and diplomacy, she has spearheaded innovative solutions to global health challenges, shaped impactful policies, and advanced national and international missions.

As the Executive Director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, she established and led the council’s operations, liaising with over 600 experts, worldwide, across government, industry, and academia. Her efforts culminated in the development of critical recommendations addressing antimicrobial resistance and interrelated One Health issues, influencing both domestic and global health strategies.

In her tenure as Deputy Director of Strategic Initiatives for the Office of Infectious Diseases and HIV/AIDS Policy, at the US Department of Health and Human Services, Dr. Musmar oversaw the formulation and implementation of national health strategies for vaccines and a range of infectious diseases including HIV/AIDS and viral hepatitis. Her leadership and technical expertise facilitated groundbreaking policies during national emergencies, including responses to the COVID-19 pandemic, and initiatives to combat congenital syphilis and childhood vaccination disruptions. Dr. Musmar holds a Ph.D. in Biodefense from George Mason University, a Master’s degree in Biomedical Science policy and Advocacy from Georgetown University, and is a Lean Six Sigma Black Belt. Fluent in English and Arabic, she is a sought-after speaker and advisor, having represented the United States at premier global health conferences.

Her published works on antimicrobial resistance, pandemic preparedness, and national health security underscore her reputation as a thought leader and innovator in public health and biodefense.

Chris Shaffer

Chris Shaffer was a music, special education teacher, and high school principal for 45 years. At the end of his educational career, he was thrust into the world of AMR infections when a number of abdominal surgeries left him with an E-coli infection which failed to respond to antibiotics. After doctors in the USA left him with little hope for a cure, diminishing health, and a bleak prognosis, he set out on his own.

Chris found success in phage therapy at the Eliava Phage Therapy Center in Tbilisi, Georgia. With phage therapy giving Chris his life back, he has dedicated his retirement years to advocating for and helping raise awareness of phage therapy used for AMR infections. He tells the story of his phage journey in a book titled, Finding Phage: How I Partnered with a Friendly Virus to Cure My Deadly Bacterial Superinfection. His website, phagetherpyusa.com helps others learn to understand the healing power of phage therapy.

Demi Christofi

Demi is an Associate Scientific Director at a medical communications agency, with a background in microbiology and a longstanding focus on antimicrobial resistance. She holds an MSc in Microbiology, where she first became interested in the global challenge of resistance and the need to bring scientific understanding to wider audiences.

Demi’s career has centred on a simple but powerful belief: that how we communicate science matters. Her work focuses on making complex data clear, engaging, and accessible – whether for healthcare professionals, policy makers, or the patients most affected by infection and resistance. She has contributed to a wide range of AMR-focused projects, including educational programmes, congress communications and stewardship initiatives.

A central thread in Demi’s work is the importance of the patient voice. She is passionate about making sure real-world experiences of treatment failure, recurrent infections, and the anxiety surrounding resistance are not lost in the data. She believes that listening to patients and involving them meaningfully is essential for shaping more effective, human-centred responses to AMR.

Demi is also a strong advocate of the One Health approach, recognising AMR as a complex, interconnected issue that spans human health, animal health, and the environment. She is particularly drawn to efforts that move beyond siloed thinking and focus on practical, joined-up solutions.

In 2025, Demi joined The AMR Narrative as an Independent Advisor, where she supports the charity’s mission to centre communication, community, and inclusion in the global AMR response.

Outside of work, she is a Girlguiding unit leader and a qualified yoga teacher. These roles reflect her commitment to care, learning, and creating supportive spaces for others.

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.